Techniques of assisted fertilization are usually preceded by ovarian s
timulation therapies. This implies the risk of development of an ovari
an hyperstimulation syndrome (OHS). With this article, clinical releva
nce, possible pathogenetic mechanisms, diagnosis, therapy and preventi
on of OHS are discussed. In addition, three patients with severe OHS a
re presented. Valid parameters for OHS risk assessment are peripheral
E2 values as well as number and diameter of follicles. Until now, the
mechanisms which lead to severe OHS are unknown, but hCG seems to trig
ger the development of symptoms, as OHS very rarely occurs without pri
or hCG application. Symptoms of severe OHS comprise ovarian enlargemen
t, fluid- and electrolyte imbalance, third space fluid accumulation, h
aemoconcentration and hypercoagulation. Only symptomatic therapy is av
ailable. The significance of vascular mediators for the development of
OHS is discussed.